82 results
424B5
OVID
Ovid Therapeutics Inc
15 Nov 23
Prospectus supplement for primary offering
4:11pm
studies and clinical trials to the satisfaction of applicable regulatory authorities.
If we are not successful in discovering, developing
8-K
EX-10.1
umj8ox0wf6bk5qliwt
3 Jan 22
Entry into a Material Definitive Agreement
7:00am